Device / Technology News

RSS

Over twenty new drug metabolism assays launched by Absorption Systems

Absorption Systems, a leader in drug safety and ADMET (absorption, distribution, metabolism, excretion and toxicity) testing, today announced the introduction of a more complete series of drug metabolism assays designed to support the pharmaceutical R&D process, from early-stage discovery through late-stage clinical development.

2 Dec 2009

URMC implements Allocade's artificial intelligence based solution to manage patient flow and logistics

The University of Rochester Medical Center (URMC) and Allocade, Inc., today announced the first installation and implementation of the On-Cue™ system in New York. URMC is utilizing the On-Cue software solution from Allocade to automate patient flow throughout the hospital and improve operational efficiencies by creating dynamic patient itineraries. The On-Cue system utilizes artificial intelligence, offering healthcare an efficient operating system that helps caregivers to effectively manage patient flow and logistics.

2 Dec 2009

American Scientific Resources commences production of its FDA approved home needle destruction device

American Scientific Resources, Inc., announces that the Disintegrator Plus(TM), the world's only FDA approved home needle destruction device (NDD), is in its first production run for ASR.

2 Dec 2009

Minnesota's first e-Patient

Minnesota's first virtual doctor's visit was conducted Monday evening, the Pioneer Press reports. The patient, Beth Piper or Hampton, Minn., learned that sleeping pills would interact badly with another medication she uses during the seven minute Webcam-enabled discussion. Her doctor, Eric Christianson, suggested using Benadryl instead.

2 Dec 2009

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the bladder.

2 Dec 2009

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

Bruker BioSpin has successfully completed the installation of the world’s first 1000 MHz ultra-high field NMR AVANCE™ spectrometer at the Centre de Resonance Magnétique Nucléaire à Très Hauts Champs (CRMN) in Lyon, France (a joint research unit of CNRS, Ecole Normale Supérieure de Lyon and Université Lyon 1).

2 Dec 2009

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Capsule, the leading provider of medical device connectivity, today announced its official release of the Capsule Neuron™. Following Capsule's recent release of their Enterprise Device Connectivity Solution, the flexible, innovative Capsule Neuron platform allows the solution to be deployed across the hospital in both high and low acuity environments.

2 Dec 2009

Accera Pharmaceuticals to implement the Veeva CRM suite of multi-tenant SaaS applications

Less than 9 months after implementing a new CRM application, Accera Pharmaceuticals began searching for a replacement. The commercial-stage biotechnology company, which launched Axona™ (a prescription-only medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease) around the same time as it implemented its current system, had quickly outgrown the generic CRM tool.

2 Dec 2009

IDN Health Systems implements PHACTS' Enterprise-Wide Inventory Management Solution

PHACTS, LLC, a leader in Pharmacy Inventory Management Systems, signed exclusive agreements in 2009 with USA IDN Health Systems and hospitals valued at $22.4 million in new business. PHACTS expects this number to grow to over $30 million by the end of 2009.

2 Dec 2009

Worldwide DRTV marketing of BioElectronics' ActiPatch and Allay brands

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.

2 Dec 2009

Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA

Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.

2 Dec 2009

Health eTouch helps to enhance communications between patients and doctors

Parents of teens know just how difficult it is to get them to talk about their personal lives, let alone their health. With only 20 percent of children with mental health problems in the United States being properly identified and treated, it is imperative that a solution be found. Doctors and researchers at Nationwide Children's Hospital are one step closer by finding a new way to get teens to open up about their health and what's really on their mind, bringing up issues that otherwise would have gone unnoticed.

2 Dec 2009

AFA to host a webinar on Catholics and IVF

On Monday, The American Fertility Association will host a webinar entitled Catholics and IVF: A Pastoral Approach, presented by Father Jon Pedigo. IVF, or In Vitro Fertilization, is a form of assisted reproductive technology (ART) often used by couples and individuals who are having difficulty conceiving a child naturally. During the IVF process, one or more embryos are implanted into a woman's uterus and the remaining, unused embryos are destroyed, frozen, or donated.

2 Dec 2009

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.

From Roche Sequencing and Life Science 2 Dec 2009

RSNA: Dec. 2, 2009 briefing and presentations

A special press briefing will be held Wednesday, Dec. 2, at 10:45 a.m. CT (11:45 a.m. ET), featuring a panel of top experts who will discuss the recent U.S. Preventive Services Task Force (USPSTF) release of revised screening mammography guidelines. Many patients, breast cancer survivors, medical experts and government authorities dispute the guidelines as being without scientific evidence.

2 Dec 2009

New hybrid catheterization table for Toshiba America Medical Systems' five-axis Infinix-i cardiovascular X-ray line

Toshiba America Medical Systems, Inc. has introduced the CAT-880B, a new hybrid catheterization table, for its five-axis InfinixTM-i cardiovascular X-ray line.

2 Dec 2009

Toshiba’s new CT system allows physicians to reduce diagnosis time for stroke

When a patient comes to a hospital’s emergency department (ED) exhibiting stroke symptoms, it can take hours to diagnose and treat the patient when time is of the essence. Toshiba’s Aquilion® ONE dynamic volume CT system has the ability to improve the quality of life for patients with neurological symptoms, especially related to stroke, by reducing diagnosis time to minutes.

2 Dec 2009

OEM's and third parties granted access to Telemis Group's PACS solutions

Telemis Group, the medical imaging company specialized in PACS (Picture Archiving and Communication System) solutions, has announced that it is to make its innovative, platform-independent technologies available to original equipment manufacturers (OEMs) and other third parties for the first time.

2 Dec 2009

MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy

MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy.

2 Dec 2009

Ege University’s surgical team completes first phase of certification training on ‘Syncardia Total Artificial Heart’

On Nov. 30 and Dec. 1, the surgical team from Ege University in Izmir, Turkey, led by Prof. Mustafa Ozbaran, head of the Transplant and Assist Device Program, completed the first phase of certification training for the SynCardia temporary CardioWest™ Total Artificial Heart in Paris.

2 Dec 2009

Device / Technology News

Over twenty new drug metabolism assays launched by Absorption Systems

URMC implements Allocade's artificial intelligence based solution to manage patient flow and logistics

American Scientific Resources commences production of its FDA approved home needle destruction device

Minnesota's first e-Patient

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Accera Pharmaceuticals to implement the Veeva CRM suite of multi-tenant SaaS applications

IDN Health Systems implements PHACTS' Enterprise-Wide Inventory Management Solution

Worldwide DRTV marketing of BioElectronics' ActiPatch and Allay brands

Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA

Health eTouch helps to enhance communications between patients and doctors

AFA to host a webinar on Catholics and IVF

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

RSNA: Dec. 2, 2009 briefing and presentations

New hybrid catheterization table for Toshiba America Medical Systems' five-axis Infinix-i cardiovascular X-ray line

Toshiba’s new CT system allows physicians to reduce diagnosis time for stroke

OEM's and third parties granted access to Telemis Group's PACS solutions

MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy

Ege University’s surgical team completes first phase of certification training on ‘Syncardia Total Artificial Heart’

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News